• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Fulminant myocarditis in an adult with 2009 pandemic influenza A (H1N1 influenza) infection

tetano

Editor, Senior Moderator
J Chin Med Assoc. 2011 Mar;74(3):130-3. Epub 2011 Feb 22.
Fulminant myocarditis in an adult with 2009 pandemic influenza A (H1N1 influenza) infection.

Liao YC, Hsieh YC, Chang WC, Huang JL, Ting CT, Wu TJ.

Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan, ROC.
Abstract

The worldwide outbreak of pandemic influenza A (H1N1 influenza) infection in 2009 caused numerous hospitalizations and deaths resulting from severe complications such as pneumonia, sepsis, and acute respiratory distress syndrome. Fulminant myocarditis caused by H1N1 infection has been reported in children but rarely in adults. We present an adult who contracted H1N1 infection followed by fulminant myocarditis. Early implementation of extra-corporeal membrane oxygenation support in conjunction with a specific anti-influenza viral medication (Oseltamivir) led to the patient's complete recovery from cardiogenic shock in 2 weeks.
Copyright ? 2011. Published by Elsevier B.V.

PMID: 21421208 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/21421208
 
Back
Top Bottom